{"disease":{"id":"mast-cell-activation-syndrome","name":"mast cell activation syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT05449444","title":"Masitinib for the Treatment of Severe Mast Cell Activation Syndrome","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":72,"lead_sponsor_name":"AB Science","has_results":false},{"nct_id":"NCT04978740","title":"Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT03406325","title":"Mast Cell Activation Test in Allergic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Hong Kong Sanatorium & Hospital","has_results":true},{"nct_id":"NCT05652907","title":"Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Quantum Biopharma","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}